Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Items 1,201–1,300 of 1,392
Kalra, S., Thacker, H. P., Bantwal, G., Jain, S., Kale, S. C., Saboo, B., Gupta, J., & Sivam, S. (2016) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.177320
Permis de conduire et diabète sucré
Cimino, L., Deneufgermain, A., & Lalau, J. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30266-2
Diabetische Notfallsituationen – die Hypoglykämie
Siegmund, T., & Schumm‐Draeger, P. (2014) · Der Diabetologe · doi:10.1007/s11428-014-1264-y
Korpi-Steiner, N. L. (2014) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000029
Particularidades no manejo do diabetes em crianças e idosos
Matheus, A. S. D. M., & Cobas, R. A. (2015) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2015.20056
Hypoglycemia: A hard obstacle to overcome in diabetes management
(2020) · doi:10.5348/e04-2015-1-ed-1
“The American Diabetes Association published a very comprehensive and concise guide for the clinical practice [17].”
Backgroundแสงรัตน์, บ., ผัดวัน, ร., ศรีธิการ, ม., et al. (2016) · Journal of The Royal Thai Army Nurses
Diabetes e cirurgia de ambulatório – protocolo de atuação no período perioperatório
Monteiro, A. M., Alves, M., & Marques, O. (2016) · Endocrinology Insights · doi:10.1016/j.rpedm.2016.06.001 · Cited by 5
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K. M., Czarniecki, C. W., Goldstein, J., Hunsicker, L. G., et al. (2016)
Management of Hypoglycemia and Impaired Awareness of Hypoglycemia in Diabetes
Seaquist, E. R. (2016) · The Endocrine Society eBooks · doi:10.1210/mtp5.9781943550043.ch22
Self-citationQian, T., Ruan, F., Sun, X., et al. (2016) · Scholars Journal of Medical Case Reports · doi:10.21276/sjmcr.2016.4.6.24
“9mmol/L in the classification of hypoglycemia [9].”
Comentarios sobre «Hipoglucemia desapercibida en personas con diabetes tipo 1»
Laureano, F. C. S., Ortega, M. D. C. A., Zaldivar, A. P., & Expósito, C. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.05.005
Protocolo de detección y prevención de la hipoglucemia en el paciente con diabetes
Carruesco, G. C., & Ballesteros, A. C. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.016
Hypoglycaemia Fear among Diabetics
Omar, S., Albsoul, A., & Alabbadi, I. (2016) · Jordan Journal of Pharmaceutical Sciences · Cited by 2
Oberlin, D. J. (2016) · ProQuest Demo Repository · Cited by 1
Care of Young Children With Diabetes in the Child Care Setting: A Position Statement of the
Siminerio, L. M., Albanese-O, A., Chiang, J. L., Hathaway, K., Jackson, C. C., Weissberg-Benchell, J. A., Wright, J. L., Yatvin, A. L., & Deeb, L. C. (2014)
Comments on “Impaired awareness of hypoglycaemia in subjects with type 1 diabetes”
Laureano, F. C. S., Ortega, M. D. C. A., Zaldivar, A. P., & Expósito, C. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.09.012
Częstość objawów hipoglikemii u chorych na cukrzycę w warunkach ambulatoryjnych
Tłuczykont, M., Molsa, M., Markowicz, A., & Strojek, K. (2014) · Via Medica Journals
Dunning, T. L. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch20
Focus on Hypoglycemia: Patient Education, Disease Management, and Prevention
Patel, D. K., Charkoudian, M., Goldman, J. D., & Couris, R. R. (2015) · Nutrition Today · doi:10.1097/nt.0000000000000127
Schwere Diabetesnotfälle schnell erkennen!
Schmidt, R., & Palitzsch, K. (2017) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-017-0398-4
The relationship between sleep and glucose control in gestational diabetes
Alnaji, A. (2017) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
L'hypoglycémie chez le patient diabétique
Maitre, S., Jaafar, J., Gastaldi, G., & Philippé, J. (2016) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2016.02701
Schwere Diabetesnotfälle erkennen und schnell reagieren
Schmidt, R., & Palitzsch, K. (2018) · Pflegezeitschrift · doi:10.1007/s41906-018-0494-9
Lau, R. S. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3n58d198
Functional in vitro studies of immunosuppressive agents in human pancreatic islets
Kloster‐Jensen, K. (2018) · NVA (Nasjonalt vitenarkiv)
Principles of Care in the Diabetic Surgical Patient
Khazai, N. B., & Hamdy, O. (2018) · Contemporary diabetes · doi:10.1007/978-3-319-89869-8_6
Anesthesia for the Pregnant Diabetic Patient
Şalvız, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-93163-0_3
Ismailov, S. I., & Vodovskaya, A. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.5.2018.142691
Rouf, R. S. B., & Pathan, M. F. (2019) · Bangladesh Journal of Medicine · doi:10.3329/bjmed.v30i1.39920
Peptide Drug Design for Diabetes and Related Metabolic Diseases
Kaarsholm, N. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_13
Strategies to mitigate hypoglycaemia in the artificial pancreas
Bondía, J., & Vehí, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00018-1
GLYCAEMIA SELF-CONTROL ROLE IN PREVENTION OF CARDIOVASCULAR DISEASES IN DIABETES MELLITUS PATIENTS
Shatskaya, O. A., & Kukharenko, S. S. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-11-166-169
Wm, V.-R. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_62
Colombat, S., & Boulin, M. (2019) · Therapies · doi:10.1016/j.therap.2019.09.002
Hypoglykämien bei Diabetes mellitus: häufig und gefährlich
Holstein, A., & Holstein, D. J. F. (2019) · Diabetes aktuell · doi:10.1055/a-1031-2237
“[7] Seaquist ER, Anderson J, Childs B et al.”
BackgroundProblem solving in type 1 diabetes for primary care nurses–part 2
Morris, D. (2019) · Independent Nurse · doi:10.12968/indn.2019.12.25
Hypoglycemic Hemiparesis Masquerading As Ischemic Stroke: When Guideline Fails
Patel, D. M., Patel, M. V., Gurumukhani, J. K., Patel, M. M., Mahadevia, H. J., & Gajjar, R. A. (2019) · Current Drug Therapy · doi:10.2174/1574885515666191227155624
Kawamura, T., & Komatsu, H. (2019) · Journal of Japan Academy of Nursing Science · doi:10.5630/jans.39.227
Scott, S. N., Riddell, M. C., & Yardley, J. E. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-33376-8_25
Problems with Adherence and Social Stigma in Adolescents with Type 1 Diabetes
Davis, L. (2020) · Bucknell Digital Commons (Bucknell University) · Cited by 2
Le glucagon nasal, une innovation bien sentie
Benhamou, P. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.07.005 · Cited by 1
Ashok, A., Abusamaan, M. S., Parker, P., Pilla, S. J., & Mathioudakis, N. N. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06225-y
Gorgzadeh, N., Taghizadeh‐Ghehi, M., & Kohneloo, A. J. (2020) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_19_111
Hypoglykaemia előfordulása a Dcont® eNAPLÓ telemedicinális támogatás 10 évre terjedő adatbázisában
Jermendy, G., Kecskés, Á., & Nagy, A. C. (2020) · Diabetologia Hungarica · doi:10.24121/dh.2020.12
Hypoglycemia In The Emergency, But What Awaits Us For Cardiac Risks In The Future?Preprint
Akhan, O., & Ardahanlı, İ. (2021) · doi:10.22541/au.161003343.32075984/v1
Петрова, М. М., Пронина, Е., & Krizhanovskaya, E. V. (2016) · Cardiosomatics · doi:10.26442/cs45277
Malone, C., Mathiason, M. A., Stenstrup, E. Z., & Tracy, M. F. (2021) · Clinical journal of oncology nursing · doi:10.1188/21.cjon.161-168
Developing the Hypoglycemia-Nursing Early Warning Score System ( Hy-Newss ): A Pilot Study
Wibisono, A. H., Kurniasih, D., Sumartiyah, E., Putri, R. N., Kurnia, D. A., Gultom, Y., & Dahlia, D. (2021) · Journal of Public Health Research · doi:10.4081/jphr.2021.2145
Glucagon in treatment of hypoglycemia - novelties
Brož, J., Malinovská, J., Brunerová, L., & Urbanová, J. (2021) · Vnitřní lékařství · doi:10.36290/vnl.2021.022 · Cited by 1
FEAR OF HYPOGLYCEMIA IN TYPE 1 DIABETES MELLITUS
Markanovic, H. (2021)
Faktor Prediktif Prognosis Pasien dengan Ensefalopati Hipoglikemia
Valentina, D. C. D. (2021) · JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia · doi:10.53366/jimki.v9i1.351
Frequency of Hypoglycemia in Severe Acute Malnutrition
Zahirzay, M. S., Chardiwal, H., & Azimee, M. A. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i45b32784
“A reverse correlation was found between pre-albumin level and mortality among hospitalized elderly patients with a decreased nutrient intake [32], and patients treated with hemodialysis and peritoneal dialysis [33].”
BackgroundMertens, M., Dauben, L., Roden, M., & Müssig, K. (2021) · Diabetes aktuell · doi:10.1055/a-1645-9436
Bilous, F. R., Donnelly, R., & DM, F. I. I. (2021) · Wiley eBooks · doi:10.1002/9781118976074.ch13
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_19 · Cited by 1
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-1 · Cited by 2
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_19-1
Mota, R. B., Lamback, E. B., Lozovey, N. R., Caarls, M. B., Arruda, M., & Neto, L. V. (2016) · Journal of Endocrinology and Metabolism · doi:10.14740/jem369w
A Review of Type 1 Diabetes (T1D): To Assist Patients' and Carers' Understanding of This Condition
O’Donnell, E., & O’Donnell, L. (2019) · IGI Global eBooks · doi:10.4018/978-1-7998-1204-3.ch002
Funnell, M. M. (2014) · Nursing · doi:10.1097/01.nurse.0000443326.88579.15
Benmayouf, T., Villoing, B., & Doumenc, B. (2019) · EMC - Urgenze · doi:10.1016/s1286-9341(19)42035-8
Marker, A. M., Monzon, A. D., Nelson, E., Clements, M. A., & Patton, S. R. (2019) · doi:10.2196/preprints.13727
Sharp, C. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-58260-3_20
(2019) · ARC Journal of Nutrition and Growth · doi:10.20431/2455-2550.0502003
Aspectos clínicos y diagnósticos de la diabetes infantil
Louvigné, M., Decrequy, A., Donzeau, A., Bouhours‐Nouet, N., & Coutant, R. (2018) · EMC - Pediatría · doi:10.1016/s1245-1789(17)88072-0 · Cited by 10
Complications métaboliques aiguës (comas chez le diabétique)
Blicklé, J.-F. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75889-8.00020-8
Tanikawa, A., Kudo, D., Ohbe, H., & Kushimoto, S. (2021) · Research Square · doi:10.21203/rs.3.rs-615999/v1
(2014) · Journal of Diabetes · doi:10.1111/1753-0407.12145
Diggs, F. J., & Lee, P. H. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.inpatienthyperglycemia_overview
Dasiglucagon for treating severe hypoglycemia in patients with diabetes
Ju, Y., Zhang, D., & Yang, J. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2103537
“Hypoglycemia is a common complication during the treatment of patients with diabetes [1,2].”
BackgroundKo, S. (2022) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2022.4.e13 · Cited by 1
Hypoglycemia: An Underrecognized Peril for Older Adults With Diabetes
Burani, J., & Davidson, P. (2022) · ADCES in Practice · doi:10.1177/2633559x221114836
Sakane, N., Kato, K., Hata, S., Nishimura, E., Araki, R., Kouyama, K., Hatao, M., Matoba, Y., Matsushita, Y., Domichi, M., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1984365/v1
Adefegha, S. A., Oboh, G., & Adewumi, S. T. (2022) · Comparative Clinical Pathology · doi:10.1007/s00580-022-03393-7
“Reports indicate that hyperglycemia could induce non-enzymatic glycosylation of various macromolecules, generation of reactive oxygen species, and alteration of endogenous antioxidants which could result in the development of chronic complications in diabetes (Seaquist et al. 2013).”
BackgroundRisk of Hospitalization in Diabetic Patients with Severe Hypoglycemia: A Single-Center StudyPreprint
Pieramati, L., Mantovani, E., Lucchini, G., & Amato, M. (2022) · Preprints.org · doi:10.20944/preprints202209.0153.v3
Mohan, V., Schmider, W., Singh, K. P., Rotthaeuser, B., Mukherjee, B., & Aravind, S. R. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_216_22
Disturbi del sonno nella donna in menopausa
Laudisio, D., Graziadio, C., Marino, F., Savastano, S., & Colao, A. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01182-6
“Negli stati di insulino-resistenza, l’iperglicemia postprandiale e la conseguente iperinsulinemia compensatoria data da un elevato carico glicemico alimentare, possono provocare ipoglicemia reattiva [29], innescando la secrezione di ormoni controre-”
BackgroundImproving flexibility in substrate metabolism: a pharmacological and lifestyle approach
Veelen, A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20230125av
Skow, R. J., Steinback, C. D., & Davenport, M. H. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2022-0277 · Cited by 1
Smith, M. D., Ridyard, C. H., Botan, V., Brewster, A., Dunmore, S., James, J., Khunti, K., Laparidou, D., Law, G. R., Mountain, P., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282987
“Hypoglycaemia, a common adverse complication of diabetes treatment [1], is often managed by patients themselves or their relatives, but severe hypoglycaemia (defined as cognitive impairment severe enough to require third-party assistance to take corrective action [2]) frequently requires attendance of an emergency med…”
BackgroundBasal insulin titration algorithms in patients with type 2 diabetes: the simplest is the best (?)
Katerenchuk, V. I. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.1.2023.1244
Rukminingsih, F., Octasari, P. M., & Danira, O. D. (2022) · JAFP (Jurnal Akademi Farmasi Prayoga) · doi:10.56350/jafp.v7i2.83
Valencia, W. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_66 · Cited by 3
Hypoglycemia: Diagnosis, Management, and Prevention
Faradji, R. N., Uribe-Wiechers, A. C., & de la Maza, E. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_45 · Cited by 2
Pharmacy stewardship to reduce recurrent hypoglycemia
Wood, M., Moses, J., Andrade, D. C., de la Cova, M., Parmar, J. R., Middlebrook, G., & Beltran, D. C. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.09.002 · Cited by 1
Alothman, M.-H., Alothman, M. H., & Moscote‐Salazar, L. R. (2023) · Journal of Neurointensive Care · doi:10.32587/jnic.2023.00661
Saienko, Y. A., Marushko, Y. Y., Ozerianska, Monashnenko, Zubovych, Iepishyna, & Mankovsky, B. (2023) · Diabetes Obesity Metabolic Syndrome · doi:10.57105/2415-7252-2023-5-02
Yudelowitz, G., & Mahyoodeen, N. G. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4646739
Modeling, Estimation, and Feedback Techniques in Type 2 Diabetes
Ahdab, M. A. (2023) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau614554303
Iqbal, A., Chow, E., Jones, T. W., & Heller, S. R. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch40
Self-citationEvaluation and Management of Inpatient Hypoglycemia
Mehta, P. B., Rov-Ikpah, E., & Rushakoff, R. J. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_3
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.